Competition in the pharmaceutical equipment industry continues to intensify, how to break through in the future?

In recent years, from the perspective of the domestic pharmaceutical machinery market as a whole, the competition between local pharmaceutical machinery companies and domestic and foreign pharmaceutical machinery has become increasingly fierce
.
In this context, the industry believes that for China to achieve higher-quality development of the pharmaceutical equipment industry, it must break through through continuous efforts in three aspects
.
Competition in the pharmaceutical equipment industry continues to intensify (picture source: pharmacy.
com) First of all, in terms of low-end products, domestic pharmaceutical machines can basically meet the needs of the domestic market
.
However, due to the low concentration of China's pharmaceutical equipment industry, most small and medium-sized enterprises lack high value-added products with independent intellectual property rights.
The stability of most pharmaceutical equipment varieties, the degree of scale and intensification of production are low, and the degree of product differentiation between different companies Therefore, in recent years, problems such as serious homogeneity in the low-end pharmaceutical equipment market have begun to continue to plague the development of the domestic low-end pharmaceutical equipment industry
.
In this regard, the industry believes that in the future, only by strengthening innovation and research and development can companies stand out
.
In fact, in recent years, the state has also actively promoted the integration of production, teaching, research and application, encouraging higher education institutions and scientific research institutions to transfer independent innovation achievements to enterprises, and encouraging more scientific and technological personnel to establish scientific and technological enterprises
.
At present, China's pharmaceutical equipment industry has gradually formed a group of pharmaceutical equipment manufacturers with strong R&D capabilities, independent intellectual property rights, and strong competitiveness, and more and more sophisticated products are constantly emerging
.
Secondly, in the high-end field, after many years of rapid development, domestic pharmaceutical machinery companies have begun to gradually rise
.
But on the whole, China's pharmaceutical equipment products are still dominated by low-end products.
Compared with imported equipment, China's pharmaceutical machinery manufacturers still have a certain gap in production technology, equipment level, and production technology
.
In addition, in terms of R&D investment, the R&D investment of large domestic pharmaceutical companies accounts for about 5-10% of revenue.
Compared with European and American countries, R&D investment is still relatively low
.
In this context, analysts pointed out that in high-end areas, more policy support and corporate attention are needed
.
Among them, domestic enterprises need to build their own core technology through continuous research and development, in order to gradually catch up with imported manufacturers.

.
In short, if the domestic pharmaceutical machine wants to catch up with foreign products, it must first develop advanced technology, make a fuss about the performance and configuration of the equipment, and further narrow the gap between the two, so as to participate in a broader and longer-lasting market competition.
In order to speed up the road to high-end
.
In addition, in terms of internationalization, as competition in the pharmaceutical equipment market continues to intensify, the quality and technology of local companies continue to improve, and the demand for overseas markets continues to increase, the international layout has already become a major development in China’s pharmaceutical equipment industry.
Trends, it is understood that the pharmaceutical machinery companies that are currently deployed in the international market ahead of schedule, such as Chutian Technology, Tofflon, etc.
, have ushered in significant overseas business growth.
In addition, some powerful medium-sized pharmaceutical machinery companies have also begun to try Contact with international customers, promote products to overseas markets, and get a certain degree of recognition
.
Behind this phenomenon reflects the improvement in quality, technology, service and other aspects of domestic pharmaceutical machinery companies
.
However, what needs to be considered is that most of China's pharmaceutical machinery companies are mainly small and medium-sized, and there are some common problems such as low level of equipment informatization and low competitiveness in the process of going global
.
Therefore, in order to further promote the growth of corporate performance and enhance the influence of domestic pharmaceutical machinery in the world, the industry believes that in the future, domestic pharmaceutical machinery companies should also accelerate the formulation of internationalization strategies, expand international markets, and continuously increase export business revenue as a share of total business.
The proportion of income
.